Skip to content
MedsAcross

Brand family

Zenzedi

Dextroamphetamine · Azurity Pharmaceuticals
United States
Presentations
7
Markets
1

Zenzedi is a brand of Dextroamphetamine marketed by Azurity Pharmaceuticals, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Dextroamphetamine
Brand owner
Azurity Pharmaceuticals
Registered in
United States
Strengths and forms
10 mg tablet, 15 mg tablet, 2.5 mg tablet, 20 mg tablet, 30 mg tablet, 5 mg tablet, 7.5 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Zenzedi 10 mg tabletOralAzurity PharmaceuticalsUS FDAAvailable on request
Zenzedi 15 mg tabletOralAzurity PharmaceuticalsUS FDAAvailable on request
Zenzedi 2.5 mg tabletOralAzurity PharmaceuticalsUS FDAAvailable on request
Zenzedi 20 mg tabletOralAzurity PharmaceuticalsUS FDAAvailable on request
Zenzedi 30 mg tabletOralAzurity PharmaceuticalsUS FDAAvailable on request
Zenzedi 5 mg tabletOralAzurity PharmaceuticalsUS FDAAvailable on request
Zenzedi 7.5 mg tabletOralAzurity PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Dextroamphetamine.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Zenzedi

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.